📰 Generic Medication News
Generic Medication News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Generic Medication. Real-time updates on events, politics, business and more.
January 25, 2024
Zydus Lifesciences announced that it has obtained approval from the USFDA to sell a generic medication for the treatment of postherpetic neuralgia. The company has received the final nod from the US Food and Drug Administration (USFDA) to produce and distribute Gabapentin tablets in strengths of 300 mg and 600 mg, as stated in a regulatory filing by Zydus Lifesciences.
January 25, 2024
India News: Zydus Lifesciences has received approval from the US Food and Drug Administration (USFDA) to market a generic medication to manage postherpetic neuralgia. Read more.
August 29, 2023
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Digital Dose Inhaler Market Size, Share & Trends Analysis Report By Product (MDI, DPI), By Indication...
August 25, 2023
/PRNewswire/ -- The "Digital Dose Inhaler Market Size, Share & Trends Analysis Report By Product (MDI, DPI), By Indication (Asthma, COPD), By Type (Branded...
August 23, 2023
JB Chemicals & Pharmaceuticals on Wednesday received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market. The companys product is the generic version of Pfizers Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.